Alpha-defensins: risk factor for thrombosis in COVID-19 infection
알파 방어소: COVID-19 감염의 혈전증 위험 인자
Clinical Trial
[키워드] Activated neutrophils
antimicrobial peptide
antimicrobial peptides
approach
block
Blood
breath
Coagulation
Colchicine
conditions
contribute
COVID-19
COVID-19 infection
COVID-19 patients
D-dimers
disease
elevated
fibrinolysis
identify
IL-6
immunohistochemistry
in vitro
Infection
Inflammation
Inflammatory
Inflammatory response
inhibited
inhibiting
interleukin
interleukin-6
lung
mitigate
Mouse models
neutrophil
neutrophil degranulation
Neutrophils
patients with COVID-19
peptides
plasma
Plasma levels
procoagulant
Prospective Study
prothrombotic
released
risk
risk factor
stimulated
thrombi
thromboembolic
thromboembolic complications
Thromboembolism
thrombosis
vasculature
α-defensins.
[DOI] 10.1111/bjh.17503 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1111/bjh.17503 PMC 바로가기 [Article Type] Clinical Trial